Episode 111: PREMIUM – New stuff you really need to know about
In episode 111, Mike and James bring you the premier edition of the new PREMIUM TEC podcast episodes. We discuss high dose versus low dose statins, we possibly put the final nail in the rosiglitazone coffin and finally report that single high annual doses of Vitamin D didn’t do what they were supposed to do. At the end we discuss whether or not the PREMIUM label really should have been given to this podcast and decide to let the listeners make that decision.
1) SEARCH – low dose (20 mg) vs high dose (80 mg) simvastatin in patients after an MI
2) Rosiglitazone – are we really done with it?
Food and Drug Administration. Briefing document:July13-14,2010 meeting of the
Endocrinologic and Metabolic Drugs Advisory Committee
3) Annual high-dose (500,000 IU) oral Vitamin D and falls and fractures in older women